Advanced Care and Clinical Research for Thyroid Eye Disease
Expert outpatient infusion therapy with access to clinical trials and emerging treatments for Thyroid Eye Disease.
Why BioSight?
BioSight Infusion Center is a specialized ambulatory infusion clinic dedicated to the treatment of Thyroid Eye Disease (TED). In addition to delivering FDA-approved infusion therapy, BioSight serves as a research-enabled site, providing eligible patients access to clinical trials and investigational therapies.
We bridge clinical care and research, offering patients options beyond standard treatment when appropriate.
What Sets BioSight Apart
- Focused expertise in Thyroid Eye Disease
- FDA-approved infusion therapy (Tepezza®)
- Access to clinical trials and research studies
- Infusion-trained nursing and research staff
- Comprehensive insurance and prior authorization support
- Comfortable outpatient environment
- Close coordination with ophthalmologists, endocrinologists, and research sponsors
About BioSight
Our Mission
To improve outcomes and expand options for patients with Thyroid Eye Disease by integrating high-quality infusion care with clinical research and innovation.
Our Vision
To become a leading outpatient center for TED treatment, research participation, and therapeutic advancement, improving access to both approved and emerging therapies.
Our Approach
BioSight was founded to address two critical gaps:
- Limited access to specialized outpatient infusion care for TED
- Limited availability of community-based clinical trial sites for TED patients
By combining infusion services with research capabilities, BioSight offers patients and providers a single, trusted center for comprehensive care.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.